MELBOURNE, Australia & PERTH, Australia, March 25, 2025--(BUSINESS WIRE)--Xcell Biosciences Australia ... technology to enhance the metabolic fitness of TILs, resulting in a potent and persistent ...
Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid ...
MELBOURNE, Australia & PERTH, Australia, March 25, 2025--(BUSINESS WIRE)--Xcell Biosciences Australia PTY LTD (Xcellbio ... The platform uses a proprietary incubation technology to enhance the ...